Use of live bacterial vaccine vectors for antigen delivery: Potential and limitations

Vaccine

Volumn 19, Issue 13-14, 2001, Pages 1573-1580

  Medina, Eva ^a   Guzmán, Carlos Alberto ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Carriers; Mucosal immunity; Vaccines

Indexed keywords

ANTIGEN; VACCINE;

BACTERIUM CARRIER; DRUG DELIVERY SYSTEM; LACTOBACILLUS; LISTERIA MONOCYTOGENES; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SALMONELLA; VACCINATION; YERSINIA ENTEROCOLITICA;

BACILLUS ANTHRACIS; BACTERIA; GENE TRANSFER, HORIZONTAL; GENETIC VECTORS; IMMUNITY; IMMUNITY, MUCOSAL; LACTOBACILLUS; LISTERIA MONOCYTOGENES; MYCOBACTERIUM BOVIS; SALMONELLA; SHIGELLA; STAPHYLOCOCCUS; VACCINES, SYNTHETIC; VIRULENCE; YERSINIA ENTEROCOLITICA;

EID: 0035825602     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00354-6     Document Type: Review

References (88)

1. New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development
2. Mucosal immunity to infection with implications for vaccine development
3. The mucosal immune system: From fundamental concepts to vaccine development
4. Mucosal immunity: Implication for vaccine development
5. Modulation of immune responses following antigen administration by mucosal route
6. Regulation of host immune responses by modification of Salmonella virulence genes
7. Pathogenicity island 2 mutants of Salmonella typhimurium are efficient carriers for heterologous antigens and enable modulation of immune responses
8. Immunity to intracellular bacteria
9. Listeria monocytogenes a promising vaccine carrier to evoke cellular immune responses
10. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus
11. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs
12. Tumor eradication by adoptive transfer of cytotoxic T lymphocytes
13. Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance
14. Induction of cell-mediated immune response s to human immunodeficiency virus type 1 Gag protein by using Listeria monocytogenes as live vaccine vector
15. Attenuated Listeria monocytogenes carrier strains can deliver an HIV-1 gp 120 T helper epitope to MHC class II-restricted human CD4+ T cells
16. Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity
17. Attenuated Listeria monocytogenes as a live vector for induction of CD8+ T cells in vivo: A study with the nucleoprotein of the lymphocytic choriomeningitis virus
18. Influenza-specific immunity induced by recombinant Listeria monocytogenes vaccines
19. A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours
20. The defined attenuated Listeria monocytogenes mpl2 mutant is a effective oral vaccine carrier to trigger a long-lasting immune response against a mouse fibrosarcoma
21. Recombinant Listeria monocytogenes vaccination eliminates papillomavirus-induced tumors and prevents papilloma formation from viral DNA
22. Regression of established B16F10 melanoma with a recombinant Listeria monocytogenes vaccine
23. Phagolysosome formation, cyclic adenosine 3′:5′-monophosphate and the fate of Salmonella typhimurium within mouse peritoneal macrophages
24. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines
25. Characterization of aromatic- and purine-dependent Salmonella typhimurium: Attenuation, persistence, and ability to induce protective immunity in BALB/c mice
26. Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic
27. Virulence and vaccine potential of phoP mutants of Salmonella typhimurium
28. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ
29. DNA adenine methylase mutants of Salmonella typhimurium show defects in protein secretion, cell invasion, and M cell cytotoxicity
30. An essential role for DNA adenine methylation in bacterial virulence
31. Delivery of class I and class II MHC-restricted T-cell epitopes of listeriolysin of Listeria monocytogenes by attenuated Salmonella
32. Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis
33. Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice
34. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens
35. Heterologous expression of the cuticular-glutathione peroxidase of lymphatic filariae in an attenuated vaccine strain of Salmonella typhimurium abrogates H-2 restriction of specific antibody responses
36. Surface expression of malarial antigens in Salmonella typhimurium: Induction of serum antibody response upon oral vaccination of mice
37. Salmonella vaccine carrier strains: Effective delivery system to trigger anti-tumor immunity by oral route
38. Interactions between Yersinia enterocolitica and rabbit ileal mucus: Growth, adhesion, penetration, and subsequent changes in surface hydrophobicity and ability to adhere to ileal brush border membrane vesicles
39. Oral immunization of mice with a live recombinant Yersinia enterocolitica O:9 strain that produces the cholera toxin B subunit
40. Yersinia enterocolitica aroA mutants as carrriers of the B subunit of the Escherichia coli heat-labile enterotoxin to the murine immune system
41. Expression of the eukaryotic Trypanosoma cruzi CRA gene in Yersinia enterocolitica and induction of an immune response against CRA in mice
42. Oral immunization against cholera toxin with a live Yersinia enterocolitica carrier in mice
43. Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes
44. Expression of the protective antigen of Bacillus anthracis by Lactobacillus casei: Towards the development of an oral vaccine against anthrax
45. Oral administration of TNP-Lactobacillus conjugates in mice: A model for evaluation of mucosal and systemic immune responses and memory formation elicited by transformed lactobacilli
46. Immunization of mice by oral colonization with live recombinant commensal streptococci
47. Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization
48. Vaginal immunization of cynomolgus monkeys with Streptococcus gordonii expressing HIV-1 and HPV 16 antigens
49. Antigenicity and immunogenicity of the V3 domain of HIV type 1 glycoprotein 120 expressed on the surface of Streptococcus gordonii
50. Bacterial vaccine vectors and bacillus Calmette-Guerin
51. Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guerin vector candidate vaccine for human immunodeficiency virus type 1 in small animals
52. A recombinant Bacillus anthracis strain producing the Clostridium perfringes Ib component induces protection against iota toxin
53. Intracytoplasmic delivery of listeriolysin O by a vaccinal strain of Bacillus anthracis induces CD8-mediated protection against Listeria monocytogenes
54. Antigen delivery by attenuated Bacillus anthracis: New prospects in veterinary vaccines
55. Bivalent vaccines against bacterial enteropathogens: Construction of live attenuated vaccine strains with two O-serotype specificities
56. Expression of Shigella sonnei lipopolysaccharide in Vibrio cholerae
57. Development of Shigella sonnei live oral vaccines based on defined rfb Inaba deletion mutants of Vibrio cholerae expressing the Shigella serotype D O polysaccharide
58. Induction of a humoral immune response to a Shiga toxin B subunit epitope expressed as a chimeric lamB protein in a Shigella flexneri live vaccine strain
59. Towards a vaccine candidate against Shigella dysenteriae 1: Expression of the Shiga toxin B-subunit in an attenuated Shigella flexneri aroD carrier strain
60. Construction and characterization of live attenuated vaccine candidates against Shigella dysenteriae type 1
61. DNA vaccines
62. Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization
63. Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes
64. Oral somatic transgene vaccination using attenuated Salmonella typhimurium
65. Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma
66. Wild type HFE protein normalizes transferrin iron accumulation in macrophages from subjects with hereditary hemochromatosis
67. CD4+ T-cell subsets: Regulation of differentiation and function
68. Intestinal nematode parasites, cytokines and effector mechanisms
69. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-gamma)
70. Vaccine strategies: Targeting helper T cell responses
71. Role of CD4+ T cells and T-independent mechanisms in acquired resistance to Salmonella typhimurium infection
72. Induction of Lyt-2+ cytotoxic T lymphocytes following primary and secondary Salmonella infection
73. Generation of a cytotoxic T-lymphocyte response using a Salmonella antigen-delivery system
74. Modulation of host immune responses stimulated by Salmonella vaccine carrier strains by using different promoters to drive the expression of the recombinant antigen
75. Extracellular export of Shiga toxin B-subunit/haemolysin A (C-terminus) fusion protein expressed in Salmonella typhimurium aroA-mutant and stimulation of B-subunit specific antibody responses in mice
76. Development of antigen-delivery systems, based on the Escherichia coli hemolysin secretion pathway
77. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis
78. The Escherichia coli hemolysin secretion apparatus-a versatile antigen delivery system in attenuated Salmonella
79. An Escherichia coli hemolysin transport system-based vector for the export of polypeptides: Export of shiga-like toxin IIe B subunit by Salmonella typhimurium aroA
80. Expression of the murine interleukin-4 gene in an attenuated aroA strain of Salmonella typhimurium: Persistence and immune response in BALB/c mice and susceptibility to macrophage killing
81. Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD908-htrA
82. Stability, immunogenicity and expression of foreign antigens in bacterial vaccine vectors
83. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: Development of a single-dose oral tetanus vaccine
84. Restricting the dispersal of recombinant DNA: Design of a contained biological catalyst
85. Universal barrier to lateral spread of specific genes among microorganisms
86. Oral delivery of foreign antigens by attenuated Salmonella: Consequences of prior exposure to the vector strain
87. Control by H-2 genes of the Th1 response induced against a foreign antigen expressed by attenuated Salmonella typhimurium
88. Genetic control of immune response to recombinant antigens carried by an attenuated Salmonella typhimurium vaccine strain: Nramp1 influences T-helper subset responses and protection against leishmanial challenge